Zevra Therapeutics Inc (ZVRA)
8.13 +0.12 (+1.50%) 12:42 ET [NASDAQ]
8.14 x 24 8.17 x 100
Realtime by (Cboe BZX)
8.14 x 24 8.17 x 100
Realtime 8.18 +0.17 (+2.12%) 09:18 ET
for Mon, Mar 24th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ZVRA | TRML | SIGA | ||
| Company | Zevra Therapeutics Inc | Tourmaline Bio Inc | Siga Technologies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.33 | 17.33 | 5.72 | ||
| High | 8.33 | 17.60 | 6.00 | ||
| Low | 8.07 | 17.06 | 5.72 | ||
| Last | 8.13 | 17.51 | 5.84 | ||
| Change | +0.12 | +0.36 | +0.23 | ||
| % Change | +1.50% | +2.10% | +4.10% | ||
| Volume | 185,635 | 50,679 | 135,869 | ||
| 20-Day Average Volume | 525,206 | 325,964 | 487,894 | ||
| Previous Close | 8.01 | 17.15 | 5.61 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.89 | 15.21 | 5.61 | ||
| 20-Day Raw Stochastic | 76.56% | 81.66% | 65.53% | ||
| 20-Day Relative Strength | 53.47% | 57.23% | 50.46% | ||
| Weighted Alpha | +26.61 | -30.39 | -26.63 | ||
| Today's Opinion | 16% Buy | 40% Sell | 88% Sell | ||
| Previous Opinion | Hold | 40% Sell | 88% Sell | ||
| Last Month's Opinion | 24% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.92% since 03/17/25 | -3.72% since 03/17/25 | +3.64% since 03/17/25 | ||
| Low | 7.81 on 03/20/25 | 16.15 on 03/20/25 | 5.44 on 03/18/25 | ||
| High | 8.40 on 03/18/25 | 18.38 on 03/18/25 | 6.00 on 03/24/25 | ||
| 1-Month | |||||
| %Chg | +9.93% since 02/24/25 | +43.51% since 02/24/25 | +2.55% since 02/24/25 | ||
| Low | 7.21 on 03/04/25 | 11.92 on 03/04/25 | 5.16 on 03/04/25 | ||
| High | 8.49 on 03/14/25 | 18.85 on 03/17/25 | 6.19 on 03/12/25 | ||
| 3-Month | |||||
| %Chg | -4.66% since 12/24/24 | -17.83% since 12/24/24 | -2.75% since 12/24/24 | ||
| Low | 7.21 on 03/04/25 | 11.87 on 02/24/25 | 5.16 on 03/04/25 | ||
| High | 8.95 on 01/03/25 | 22.21 on 01/07/25 | 6.61 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | -0.97% since 09/24/24 | -25.35% since 09/24/24 | -27.15% since 09/24/24 | ||
| Low | 6.61 on 10/01/24 | 11.87 on 02/24/25 | 5.16 on 03/04/25 | ||
| High | 9.76 on 11/25/24 | 29.79 on 10/18/24 | 8.00 on 09/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 433,469 | 440,498 | 400,762 | ||
| Shares Outstanding, K | 54,116 | 25,685 | 71,437 | ||
| Annual Sales | 23,610,000 | 0 | 138,720,000 | ||
| Annual Net Income | -105,510,000 | -73,210,000 | 59,210,000 | ||
| Last Quarter Sales | 12,040,000 | 0 | 81,470,000 | ||
| Last Quarter Net Income | -35,740,000 | -22,240,000 | 45,760,000 | ||
| 60-Month Beta | 1.98 | 2.35 | 0.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.67 on 03/11/25 | -0.86 on 03/13/25 | 0.63 on 03/11/25 | ||
| Latest Earnings Date | 05/14/25 | 05/12/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.88 | ||